Australia, Hong Kong, India, Middle East, Singapore, South Africa, South Korea, Taiwan, Thailand Investigators
Bristol-Myers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support our medical plans in the following therapeutic areas: cardiovascular/metabolics, neuroscience, cancer, immunology and virology.
Australia, Hong Kong, South Korea, Taiwan, Thailand, Singapore, Middle East, India, and South Africa Investigators, click here.
The Bristol-Myers Squibb ISR application process provides a framework and allows investigators to work from a common set of criteria, requirements and schedule of events. The process is designed to ensure scientific rigor and patient safety while supporting unique research ideas and providing insights into areas of unmet medical need.
Requests for Research Proposals are not to be interpreted as suggesting that any product is safe or effective for an investigational use or recommended for any use outside of its approved labeling. Bristol-Myers Squibb does not guarantee support. Please note that studies may be submitted for “drug-only” support as well as drug & funding support. Support is solely recognized at the time of full execution of the clinical research agreement.
Please click here to agree and return to a saved application.
For all other countries, click here.
Click here for trademark information on Bristol-Myers Squibb products.